# Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

> **NCT01302119** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 604 (actual)

## Conditions studied

- Onychomycosis of Toenails

## Interventions

- **DRUG:** AN2690 Topical Solution, 5%
- **DRUG:** Solution Vehicle

## Key facts

- **NCT ID:** NCT01302119
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2012-12-31
- **Final completion:** 2013-02-20
- **Target enrollment:** 604 (ACTUAL)
- **Last updated:** 2019-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01302119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01302119, "Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01302119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*